Connect Biopharma Holdings Limited has announced the initiation of its Phase 2 Seabreeze STAT Asthma study, which aims to evaluate the safety and efficacy of rademikibart in treating acute ...

Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial. Fifty patients who had relapsed (n=25) after or were resistant (n = 25) to chemotherapy were ...

Serum aminotransferase elevation during and following treatment of childhood acute lymphoblastic leukemia. Twenty-nine patients who had relapsed after an initial response (n = 8) or were refractory (n ...